Related Experiment Videos
Central mechanism of vinblastine inhibitory effect on experimental carcinogenesis
V K Gurkalo1, N I Volfson, G B Pliss
1N.N. Petrov Research Institute of Oncology, USSR Ministry of Public Health; Leningrad.
Abstract:
In the experiments carried out on white male rats the effect of vinblastine on the development of malignant stomach tumours induced with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) has been studied. The combined administration of MNNG and vinblastine inhibits the experimental carcinogenesis at the stage of "intestinalization" and decreases the indicence of stomach adenocarcinomas by 3-fold. Pharmacological analysis using the application of apomorphine stereotypy showed the antagonism of MNNG and vinblastine at the level of central parts of the autonomic nervous system due to the inhibition of axoplasmic transport of catecholamines. These results confirm the earlier data on the essential role of catecholamines in the mechanisms of carcinogenic action of nitrosamines.
Insights
Vinblastine inhibits stomach cancer development in rats when combined with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). This combination reduces adenocarcinoma incidence and suggests catecholamines play a key role in nitrosamine carcinogenesis.
Area of Science:
- Oncology
- Pharmacology
- Gastroenterology
Background:
- N-methyl-N itro-N-nitrosoguanidine (MNNG) is a known inducer of experimental stomach tumors.
- Nitrosamines are implicated in the mechanisms of carcinogenic action.
- Catecholamines are essential in these carcinogenic processes.
Purpose of the Study:
- To investigate the effect of vinblastine on MNNG-induced stomach carcinogenesis in rats.
- To explore the potential antagonism between MNNG and vinblastine.
- To confirm the role of catecholamines in nitrosamine-induced cancer.
Main Methods:
- Induction of stomach tumors in white male rats using MNNG.
- Combined administration of MNNG and vinblastine.
- Pharmacological analysis using apomorphine stereotypy to assess autonomic nervous system activity.
Main Results:
- Combined MNNG and vinblastine administration inhibited experimental carcinogenesis at the "intestinalization" stage.
- The incidence of stomach adenocarcinomas decreased by threefold in the combined treatment group.
- Pharmacological analysis indicated antagonism between MNNG and vinblastine, linked to inhibition of axoplasmic transport of catecholamines.
Conclusions:
- Vinblastine inhibits MNNG-induced stomach carcinogenesis in rats.
- The findings support the critical role of catecholamines in the carcinogenic mechanisms of nitrosamines.
- Antagonism between MNNG and vinblastine occurs at the central autonomic nervous system level, affecting catecholamine transport.